404 related articles for article (PubMed ID: 28702323)
1. AAV-mediated pancreatic overexpression of
Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
[TBL] [Abstract][Full Text] [Related]
2. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
Flores RR; Zhou L; Robbins PD
Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
[TBL] [Abstract][Full Text] [Related]
3. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
4. AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice.
Rehman KK; Trucco M; Wang Z; Xiao X; Robbins PD
Mol Ther; 2008 Aug; 16(8):1409-16. PubMed ID: 18560422
[TBL] [Abstract][Full Text] [Related]
5. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.
Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD
Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
Prasad KM; Yang Z; Bleich D; Nadler JL
Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
[TBL] [Abstract][Full Text] [Related]
8. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.
Huang SH; Chu CH; Yu JC; Chuang WC; Lin GJ; Chen PL; Chou FC; Chau LY; Sytwu HK
Diabetologia; 2010 Nov; 53(11):2389-400. PubMed ID: 20683574
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
12. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
13. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
[TBL] [Abstract][Full Text] [Related]
14. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice.
Xu A; Zhu W; Li T; Li X; Cheng J; Li C; Yi P; Liu L
Mol Med Rep; 2015 Sep; 12(3):3881-3889. PubMed ID: 25998958
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
[TBL] [Abstract][Full Text] [Related]
17. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
[TBL] [Abstract][Full Text] [Related]
18. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice.
Hu CM; Lin HH; Chiang MT; Chang PF; Chau LY
Diabetes; 2007 May; 56(5):1240-7. PubMed ID: 17303808
[TBL] [Abstract][Full Text] [Related]
19. In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9.
Jimenez V; Ayuso E; Mallol C; Agudo J; Casellas A; Obach M; Muñoz S; Salavert A; Bosch F
Diabetologia; 2011 May; 54(5):1075-86. PubMed ID: 21311856
[TBL] [Abstract][Full Text] [Related]
20. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
